Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials

about

Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis.

P2860

Q36197277-7BABAC30-0E15-4FC0-9D82-D80E5C589127 Q37391865-0F8E1CEF-E35A-454D-8C43-13E155B94733

P2860

Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials

Item

http://www.wikidata.org/entity/Q35820055

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Clinical outcomes and survival ...... nts in phase I clinical trials

@ast

Clinical outcomes and survival ...... nts in phase I clinical trials

@en

type

Item

label

Clinical outcomes and survival ...... nts in phase I clinical trials

@ast

Clinical outcomes and survival ...... nts in phase I clinical trials

@en

prefLabel

Clinical outcomes and survival ...... nts in phase I clinical trials

@ast

Clinical outcomes and survival ...... nts in phase I clinical trials

@en

P1476

Clinical outcomes and survival ...... nts in phase I clinical trials

@en

P2093

Alex Mejia

http://www.w3.org/2001/XMLSchema#string

Andrew Brenner

http://www.w3.org/2001/XMLSchema#string

Benjamin Ehler

http://www.w3.org/2001/XMLSchema#string

Devalingam Mahalingam

http://www.w3.org/2001/XMLSchema#string

Helen Parsons

http://www.w3.org/2001/XMLSchema#string

John Sarantopoulos

http://www.w3.org/2001/XMLSchema#string

Laeeq Malik

http://www.w3.org/2001/XMLSchema#string

Martin Goros

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

The changing natural history of renal cell carcinoma.

P304

359-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLGC.2014.01.011

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24582088

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

4492113

http://www.w3.org/2001/XMLSchema#string

Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials

about

P2860

P2860

Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932